Brief: Immunovia Expands Its Lung Cancer Program Based On Encouraging Results From Current Discovery Study

Immunovia AB (publ)

26/06/2020 08:06

June 26 (Reuters) - Immunovia AB (publ)  IMMNOV.ST :
    * IMMUNOVIA EXPANDS ITS LUNG CANCER PROGRAM BASED ON
ENCOURAGING
RESULTS FROM THE CURRENT DISCOVERY STUDY
    * WITH RECENT CAPITAL RAISE, IMMUNOVIA IS FULLY FINANCED TO
EXPAND
DISCOVERY PROCESS IN LUNG CANCER.
    * NEXT STEP IN LUNG CANCER PROGRAM EXPANSION IS A STUDY OF A
LARGER COHORT OF FRESH LUNG CANCER SAMPLES THAT BEST MIRRORS
COMMERCIAL ENVIRONMENT.
    * RESULTS OF CURRENT STUDY IN LUNG CANCER STRONGLY SUPPORTS
AN
EXPANSION INTO NEXT STAGE IN DISCOVERY PROCESS

Source text for Eikon:  ID:nWkr6LjW06 
Further company coverage:  IMMNOV.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))